Manufacturing Incentives, Flexible Regulations Seen As Remedy For EU Drug Shortages

A committee of influential politicians in Europe are calling for measures that will see the EU become more self-sufficient in the production of medicines, thereby reducing medicine shortages and dependence on imports from third countries.

Out_Of_Stock
Medicines Shortages Under the Microscope at the European Parliament

ENVI, the European Parliament’s Environment, Public Health and Food Safety Committee, has adopted a draft report backing measures to tackle the ongoing problem of medicine shortages in the EU. The committee wants to incentivize more European manufacturing and better coordination among the EU member states, for example, by adopting wider use of joint procurement of medicines.

The committee voted to the report, on 14 July. There were 79 votes in favor of adoption, one against and...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography